+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Personalized Nanotechnology for Cell & Gene Therapies Market by Therapy Type (Cell Therapy, Gene Therapy), Nanotechnology Type (Nanocarrier Design, Nanodevices, Nanoencapsulation), Application, End User - Global Forecast 2025-2030- Product Image
Personalized Nanotechnology for Cell & Gene Therapies Market by Therapy Type (Cell Therapy, Gene Therapy), Nanotechnology Type (Nanocarrier Design, Nanodevices, Nanoencapsulation), Application, End User - Global Forecast 2025-2030- Product Image
Sale

Personalized Nanotechnology for Cell & Gene Therapies Market by Therapy Type (Cell Therapy, Gene Therapy), Nanotechnology Type (Nanocarrier Design, Nanodevices, Nanoencapsulation), Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6055636
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The landscape of advanced therapeutics is rapidly evolving, as personalized nanotechnology for cell and gene therapies continues to shape the next generation of healthcare. Senior decision-makers require strategic clarity and actionable insights to navigate this dynamic environment, where scientific progress, regulatory alignment, and commercial transformation intersect.

Market Snapshot: Personalized Nanotechnology for Cell & Gene Therapies

The Personalized Nanotechnology for Cell & Gene Therapies Market grew from USD 855.08 million in 2024 to USD 1.00 billion in 2025. It is expected to continue growing at a CAGR of 19.29%, reaching USD 2.46 billion by 2030. This expansion reflects ongoing innovation in nanoscale delivery and gene modification, driven by increasing demand for precise, patient-specific treatment options and the rapid translation of research into clinical applications. The market’s trajectory is influenced by developments in modular manufacturing, cross-disciplinary collaborations, and adaptive regulatory frameworks that collectively support commercialization and access to advanced therapies.

Scope & Segmentation of the Personalized Nanotechnology Market

  • Therapy Types: Immune cell therapy, induced pluripotent stem cells, mesenchymal stem cells, stem cell therapy, CRISPR technology, gene modification methods, non-viral vectors, and delivery mechanisms.
  • Nanotechnology Types: Nanocarrier design, nanodevices, nanoencapsulation, nanomaterials, nanomedicine, nanostructure imaging.
  • Applications: Cancer therapies, treatment of cardiovascular diseases, inherited genetic disorders, neurological disorder interventions.
  • End Users: Diagnostic centers, healthcare facilities, pharmaceutical companies, research institutions.
  • Regional Coverage: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East, Africa (including key markets such as United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Companies Analyzed: A comprehensive range from global conglomerates to emerging innovators, including AbbVie Inc., Amgen Inc., AstraZeneca PLC, Novartis AG, Pfizer Inc., Thermo Fisher Scientific Inc., among others.

Key Takeaways: Strategic Insights for Senior Stakeholders

  • Programmable nanocarriers now enable targeted delivery and controlled payload release, enhancing both precision and therapeutic outcomes for advanced therapies.
  • Integration of modular manufacturing and real-time analytics streamlines the path from research to clinical application and optimizes batch quality.
  • Breakthroughs in immune cell engineering, bolstered by nanomaterials, are rapidly expanding the potential of cell-based treatments across diverse indications.
  • Stakeholder collaboration from academic and industry partnerships to cross-sector consortia accelerates technology transfer and market entry strategies.
  • Increasing adoption of AI-enabled digital health platforms and predictive analytics elevates patient-centric care by enabling adaptive dosing and monitoring.

Tariff Impact on Supply Chains and Sourcing Strategies

The introduction of new United States tariffs on nanotechnology components in 2025 has prompted significant shifts in sourcing and supplier management. Manufacturers are reconfiguring supply chains to manage increased duties, moving toward local and near-shore production, and initiating cross-border collaborations. These adjustments are catalyzing domestic fabrication investments, while organizations relying on imports face extended lead times and margin pressures. In the long run, the increased regionalization is driving both resilience and diversification within the global value chain.

Methodology & Data Sources

This report employs a rigorous methodology, integrating in-depth interviews with industry experts, a comprehensive review of scientific and regulatory literature, and sophisticated data analytics. Key opinion leaders from academia, regulatory agencies, and the commercial sector contributed nuanced perspectives, while advanced analysis techniques enabled robust synthesis and validation of market trends.

Why This Report Matters

  • Enables executive planning and investment by distilling complex technology trends into actionable insights and strategic roadmaps aligned with regulatory and market changes.
  • Supports risk mitigation and growth strategies by mapping the impact of tariff dynamics, supply chain adaptation, and regulatory developments.
  • Empowers decision-makers to benchmark competitive strategies, identify collaboration opportunities, and align R&D investments with emerging therapeutic frontiers.

Conclusion

This report provides senior leaders with a holistic view of the personalized nanotechnology for cell and gene therapies market, combining segmentation, technology assessment, and market dynamics for informed decision-making. Stakeholders positioning themselves at the nexus of nanotechnology and advanced therapeutics will be well prepared for continued market transformation and competitive advantage.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Regulatory harmonization efforts accelerating approval pathways for nanocarrier-based CAR T cell therapies
5.2. Integration of artificial intelligence in the design of personalized nanocarriers for gene editing applications
5.3. Development of lipid nanoparticle platforms optimized for mRNA delivery in ex vivo cell therapy manufacturing
5.4. Emergence of biodegradable polymeric nanoparticles for targeted gene therapy in solid tumor treatments
5.5. Clinical translation challenges and milestones for patient-specific exosome mimetic nanovesicles in gene delivery
5.6. Next generation electroporation-enabled nanostraw devices enabling high efficiency intracellular cargo delivery for personalized therapies
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Personalized Nanotechnology for Cell & Gene Therapies Market, by Therapy Type
8.1. Introduction
8.2. Cell Therapy
8.2.1. Immune Cell Therapy
8.2.2. Induced Pluripotent Stem Cells
8.2.3. Mesenchymal Stem Cells
8.2.4. Stem Cell Therapy
8.3. Gene Therapy
8.3.1. CRISPR Technology
8.3.2. Delivery Mechanisms
8.3.3. Gene Modification Methods
8.3.4. Non-Viral Vectors
9. Personalized Nanotechnology for Cell & Gene Therapies Market, by Nanotechnology Type
9.1. Introduction
9.2. Nanocarrier Design
9.3. Nanodevices
9.4. Nanoencapsulation
9.5. Nanomaterials
9.6. Nanomedicine
9.7. Nanostructure Imaging
10. Personalized Nanotechnology for Cell & Gene Therapies Market, by Application
10.1. Introduction
10.2. Cancer Therapies
10.3. Cardiovascular Diseases
10.4. Inherited Genetic Disorders
10.5. Neurological Disorders
11. Personalized Nanotechnology for Cell & Gene Therapies Market, by End User
11.1. Introduction
11.2. Diagnostic Centers
11.3. Healthcare Facilities
11.4. Pharmaceutical Companies
11.5. Research Institutions
12. Americas Personalized Nanotechnology for Cell & Gene Therapies Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Personalized Nanotechnology for Cell & Gene Therapies Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Personalized Nanotechnology for Cell & Gene Therapies Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. AbbVie Inc.
15.3.2. Amgen Inc.
15.3.3. Arcturus Therapeutics, Inc.
15.3.4. AstraZeneca PLC
15.3.5. BASF Pharma Solutions
15.3.6. BlueWillow Biologics Inc.
15.3.7. Bristol-Myers Squibb Company
15.3.8. Camurus AB
15.3.9. Celgene, Inc.
15.3.10. Cristal Therapeutics
15.3.11. Cytimmune Sciences
15.3.12. Eisai Co., Ltd.
15.3.13. EyePoint Pharmaceuticals
15.3.14. Gilead Sciences Inc.
15.3.15. GlaxoSmithKline PLC
15.3.16. Hoffmann-La Roche Ltd
15.3.17. Ipsen Pharma
15.3.18. Johnson & Johnson
15.3.19. Merck KGaA
15.3.20. Nanobiotix SA
15.3.21. Novartis AG
15.3.22. Pfizer Inc.
15.3.23. Spark Therapeutics, Inc.
15.3.24. Teva Pharmaceutical Industries Limited
15.3.25. Thermo Fisher Scientific Inc.
16. Research AI17. Research Statistics18. Research Contacts19. Research Articles20. Appendix
List of Figures
FIGURE 1. PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET: RESEARCHAI
FIGURE 24. PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET: RESEARCHSTATISTICS
FIGURE 25. PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET: RESEARCHCONTACTS
FIGURE 26. PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY IMMUNE CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY IMMUNE CELL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY STEM CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY STEM CELL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CRISPR TECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CRISPR TECHNOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY DELIVERY MECHANISMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY DELIVERY MECHANISMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE MODIFICATION METHODS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE MODIFICATION METHODS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NON-VIRAL VECTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NON-VIRAL VECTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOCARRIER DESIGN, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOCARRIER DESIGN, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANODEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANODEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOENCAPSULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOENCAPSULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOMATERIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOMATERIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOMEDICINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOMEDICINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOSTRUCTURE IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOSTRUCTURE IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CANCER THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CANCER THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY INHERITED GENETIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY INHERITED GENETIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY HEALTHCARE FACILITIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY HEALTHCARE FACILITIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 97. CANADA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 98. CANADA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 99. CANADA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 100. CANADA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 101. CANADA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 102. CANADA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 103. CANADA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 104. CANADA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 105. CANADA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 106. CANADA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 107. CANADA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. CANADA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. MEXICO PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 110. MEXICO PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 111. MEXICO PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 112. MEXICO PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 113. MEXICO PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 114. MEXICO PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 115. MEXICO PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 116. MEXICO PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 117. MEXICO PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 118. MEXICO PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 119. MEXICO PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. MEXICO PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 160. UNITED KINGDOM PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 162. UNITED KINGDOM PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 164. UNITED KINGDOM PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 166. UNITED KINGDOM PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 168. UNITED KINGDOM PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. GERMANY PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 172. GERMANY PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 173. GERMANY PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 174. GERMANY PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 175. GERMANY PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 176. GERMANY PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 177. GERMANY PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 178. GERMANY PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 179. GERMANY PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 180. GERMANY PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 181. GERMANY PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. GERMANY PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. FRANCE PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 184. FRANCE PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 185. FRANCE PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 186. FRANCE PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 187. FRANCE PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 188. FRANCE PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 189. FRANCE PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 190. FRANCE PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 191. FRANCE PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 192. FRANCE PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 193. FRANCE PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. FRANCE PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. RUSSIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 196. RUSSIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 197. RUSSIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 198. RUSSIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 199. RUSSIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 200. RUSSIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 201. RUSSIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 202. RUSSIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 203. RUSSIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 204. RUSSIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 205. RUSSIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. RUSSIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. ITALY PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 208. ITALY PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 209. ITALY PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 210. ITALY PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 211. ITALY PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 212. ITALY PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 213. ITALY PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 214. ITALY PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 215. ITALY PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 216. ITALY PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 217. ITALY PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. ITALY PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. SPAIN PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 220. SPAIN PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 221. SPAIN PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 222. SPAIN PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 223. SPAIN PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 224. SPAIN PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 225. SPAIN PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 226. SPAIN PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 227. SPAIN PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 228. SPAIN PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 229. SPAIN PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. SPAIN PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 237. UNITED ARAB EMIRATES PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 238. UNITED ARAB EMIRATES PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 239. UNITED ARAB EMIRATES PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 240. UNITED ARAB EMIRATES PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 241. UNITED ARAB EMIRATES PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. UNITED ARAB EMIRATES PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 244. SAUDI ARABIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 246. SAUDI ARABIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 248. SAUDI ARABIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA PERSONALIZED NANOTECHNOLOGY FOR CELL & GENE THERAPIES MARKET SIZE, BY NANOTECHNOLOGY TYPE, 2018-2024 (USD MILLIO

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Personalized Nanotechnology for Cell & Gene Therapies market report include:
  • AbbVie Inc.
  • Amgen Inc.
  • Arcturus Therapeutics, Inc.
  • AstraZeneca PLC
  • BASF Pharma Solutions
  • BlueWillow Biologics Inc.
  • Bristol-Myers Squibb Company
  • Camurus AB
  • Celgene, Inc.
  • Cristal Therapeutics
  • Cytimmune Sciences
  • Eisai Co., Ltd.
  • EyePoint Pharmaceuticals
  • Gilead Sciences Inc.
  • GlaxoSmithKline PLC
  • Hoffmann-La Roche Ltd
  • Ipsen Pharma
  • Johnson & Johnson
  • Merck KGaA
  • Nanobiotix SA
  • Novartis AG
  • Pfizer Inc.
  • Spark Therapeutics, Inc.
  • Teva Pharmaceutical Industries Limited
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages199
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1005.66 million
Forecasted Market Value ( USD ) by 2030 $ 2464.62 million
Compound Annual Growth Rate19.2%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Personalized Cell & Gene Therapies Market by Therapy Type (Cell Therapy, Gene Therapy), Patient Type (Adult, Geriatric, Pediatric), Therapeutic Area, End User - Global Forecast 2025-2030 - Product Image

Personalized Cell & Gene Therapies Market by Therapy Type (Cell Therapy, Gene Therapy), Patient Type (Adult, Geriatric, Pediatric), Therapeutic Area, End User - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Natural Killer (NK) Cell Therapy Clinical Trials, Proprietary Technologies, Collaborations & Market Opportunity Insight 2025 - Product Image

Natural Killer (NK) Cell Therapy Clinical Trials, Proprietary Technologies, Collaborations & Market Opportunity Insight 2025

  • Report
  • 320 Pages
  • Global
From
Cell & Gene Therapy Drug Delivery Devices Market by Device Type (Autoinjector, Implantable Pump, Infusion Pump), End User (Clinic, Homecare, Hospital), Product Type, Therapy Type, Distribution Channel - Global Forecast 2025-2030 - Product Image

Cell & Gene Therapy Drug Delivery Devices Market by Device Type (Autoinjector, Implantable Pump, Infusion Pump), End User (Clinic, Homecare, Hospital), Product Type, Therapy Type, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Gene Transfer Technologies Market by Product (Instruments, Kits, Assays), Mode (Viral (Retrovirus, Adenovirus, AAV), Non-viral (Electroporation, Gene Gun)), Method (In-Vivo, In-vitro), Application, (Gene Therapy, Research) - Global Forecast to 2029 - Product Image

Gene Transfer Technologies Market by Product (Instruments, Kits, Assays), Mode (Viral (Retrovirus, Adenovirus, AAV), Non-viral (Electroporation, Gene Gun)), Method (In-Vivo, In-vitro), Application, (Gene Therapy, Research) - Global Forecast to 2029

  • Report
  • 525 Pages
  • Global
From
Cell Sheet-based Gene Therapy Market - A Global and Regional Analysis: Focus on Technology Type, Cell-sheet Type, Source Type, Application Type, End User, and Regional Analysis - Analysis and Forecast, 2025-2035 - Product Image

Cell Sheet-based Gene Therapy Market - A Global and Regional Analysis: Focus on Technology Type, Cell-sheet Type, Source Type, Application Type, End User, and Regional Analysis - Analysis and Forecast, 2025-2035

  • Report
  • 128 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.